
Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?
Lung Cancer Update
00:00
Drug Development Pathways for ADCs
There are two drug development pathways for ADCs. One is the precision pathway, which is personally my preferred way of developing drugs. The HER2 mutant story is the prototype for that. And I hope to develop more for HER2 amplification than many other targets down the track. But certainly, I'm hoping for a more precision drug development pathway.
Transcript
Play full episode